Nasdaq · CIK 0001527728
LNAI Lunai Bioworks Inc.
F
0 / 100
Material weaknesses
3
Restatements
1
Auditor changes
0
Late filings
0
Quarters with open weakness
1
Remediations
0
Deductions
100
Remediation credit
0
Trailing 24 months from 2024-11-07. Rubric v1. How this is scored.
Disclosures, in the company's words
“On March 19, 2025, following the Audit Committee s February 18, 2025 determination that the Company s previously issued financial statements for the quarter ended March 31, 2024, the fiscal year ended June 30, 2024 and the quarter ended September 30, 2024 should be restated”
“The material weakness is attributable to the Company not having adequate resources to address complex accounting matters.”
“Based on that evaluation, management concluded that, as of June 30, 2026, the Company s internal control over financial reporting was not effective due to a material weakness.”
“Based upon that evaluation, the Certifying Officers concluded that, as of June 30, 2026, our disclosure controls and procedures were not effective in ensuring that the information we were required to disclose in reports that we file or submit under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized, and reported within the time periods specified in SEC rules and forms.”
“management concluded that our disclosure controls and procedures and our internal control over financial reporting were not effective as of June 30, 2026, due to a material weakness attributable to the Company not having adequate resources to address complex accounting matters.”
“We have identified a material weakness in our internal control over financial reporting. If we fail to remediate the material weakness, or otherwise fail to maintain effective internal control over financial reporting, our ability to report our financial results accurately and timely could be adversely affected.”
“We have identified a material weakness in our internal control over financial reporting, and our disclosure controls and procedures and internal control over financial reporting were not effective as of June 30, 2026.”
“We have identified a material weakness in our internal control over financial reporting, and our disclosure controls and procedures and internal control over financial reporting were not effective as of June 30, 2026.”
Filings read
- 10-K · 2026-10-13read
- 10-Q · 2026-05-15queued
- 10-Q · 2026-02-17queued
- 10-Q · 2025-11-14queued
- 10-K · 2025-09-29queued
- 10-Q · 2025-05-15queued
- 10-K/A · 2025-02-19queued
- 10-Q/A · 2025-02-19queued
- 10-Q/A · 2025-02-19queued
- 10-Q · 2025-02-19queued
- 8-K · 2025-02-19queued
- 10-Q · 2024-11-14queued
Think something here is wrong? Request a correction. Open corrections hide the affected disclosure until resolved.